Replacing one amino-acid residue can create a compound with different stability and binding behavior. Results from that analogue should not be silently transferred to the parent peptide. Primary study
What was reported
Researchers compared GHK with two synthetic analogues in which the histidine residue was replaced. Multiple chemical methods examined copper-complex formation. The synthetic compounds showed stability in human serum over the tested observation period and comparable or greater activity in an in-vitro cell-growth assay. Complex composition depended on the chemical conditions. Primary report
Our appraisal: serum incubation is not human pharmacokinetics
Incubating a compound in a serum sample tests degradation under that preparation's conditions. It does not measure distribution, tissue uptake, renal clearance, or the full metabolism of a living person. A stability interval should not be converted into a human half-life.
The identity of the stable compound matters just as much. If an analogue resists degradation, that finding cannot establish that unmodified GHK behaves identically. The purpose of structural modification may be precisely to change that behavior.
Copper coordination introduces another context dependence. The number and arrangement of participating groups can vary with solution conditions. A simple product label does not describe every species that can exist during an experiment.
Cell growth is also a bounded biological endpoint. Increased growth in a culture medium is not automatically desirable in every tissue or disease context, and it does not establish clinical regeneration.
This paper contributes to structure–activity and coordination-chemistry research. It supports careful comparison of defined molecules, not a universal stability claim, a clinical exposure schedule, or equivalence among all products called copper peptides.
Frequently asked questions
Were synthetic analogues included?
Yes, two.
Which residue was replaced?
Histidine.
Was stability tested in serum samples?
Yes.
Is that a human half-life study?
No.
Can analogue stability be assigned to GHK automatically?
No.
Was cell-growth activity measured?
Yes, in vitro.
Does that establish clinical regeneration?
No.